Drizzle Fog/Mist 45°
Tag:

Stéphane Bancel

News
COVID-19: Moderna Seeks Full FDA Vaccine Approval COVID-19: Moderna Seeks Full FDA Vaccine Approval
Covid-19: Moderna Seeks Full FDA Vaccine Approval With six months having passed since Moderna began clinical trials for its COVID-19 vaccine, the pharmaceutical company is seeking full approval from the Food and Drug Administration. Moderna, which currently has emergency use authorization from the FDA to distribute its vaccine, reported in its latest trial data that it has proven 90 percent effective in preventing the symptoms of COVID-19, and 95 percent effective in the most severe cases of the virus. Currently, no COVID-19 vaccine is fully approved by the FDA, but three - Moderna, Pfizer, and the currently questionable Johnson & John…

SHARE

by Zak Failla
News
COVID-19: Here's When Moderna Booster Shot Will Be Available For Those Who Got Both Doses COVID-19: Here's When Moderna Booster Shot Will Be Available For Those Who Got Both Doses
Covid-19: Here's When Moderna Booster Shot Will Be Available For Those Who Got Both Doses Moderna is working on a booster shot for its two-dose COVID-19 vaccine that will be made available by the fall to help avoid another surge of new cases over the winter. CEO Stephane Bancel said on CNBC that the company “wants to make sure there are boost vaccines available in the fall so that we protect people as we go into the next fall and winter season in the U.S.” Last month, the National Institutes of Health began testing several versions of boosters from Moderna that could potentially be used to combat variants of COVID-19, including the South African strain that has flummoxed resear…

SHARE

by Zak Failla